Engineering proteins to tackle life-threatening diseases with an eye on accessibility.
Proteinea has raised $4.7M in total funding. The most recent round was Seed. The last funding was announced in June 2024.
Proteinea's investors include 500 Global, Shorooq Partners, SOSV, IndieBio, Sawari Ventures.
Proteinea is headquartered in Boston, United States.
Engineering proteins to tackle life-threatening diseases with an eye on accessibility.
Proteinea is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Proteinea — Funding & Investors." VCBacked, June 1, 2024, https://www.vcbacked.co/company/proteinea. Accessed July 19, 2026.
VCBacked. (2024). Proteinea — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/proteinea
{{cite web |title=Proteinea — Funding & Investors |url=https://www.vcbacked.co/company/proteinea |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated